International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Drug Use

Drug Use


As per available reports about 36 open access articles, 150 conferences, 39 national symposiums are presently dedicated exclusively to Drug use and about 63 speakers gave presentations on Drug use.

The term “drug use” can describe an individual who uses a substance that can change how their body and mind works. Types of drug users include recreational drug user and prescription drug user.

OMICS International 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies  and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

There have been rapid and remarkable changes over the recent past in treating Parkinson's disease. The development of new drugs and an understanding of how best to use them and the older drugs have significantly improved the quality of life of people with the disease. Choices about medications made early in the course of the disease have a strong impact on the long-term course of the illness. While none is without side effects, available drugs can greatly enhance the quality of life of a Parkinson's patient, sometimes restoring function to nearly normal for some period of time. Over time, as the disease progresses, drug dosing is adjusted to best meet a patient's symptomatic needs. There are no drug treatments available that can provide a cure for Alzheimer's disease. However, medicines have been developed that can improve symptoms, or temporarily slow down their progression, in some people. There are two main types of medication used to treat Alzheimer's disease - cholinesterase inhibitors and NMDA receptor antagonists - which work in different ways. Cholinesterase inhibitors include donepezil hydrochloride (Aricept), rivastigmine (Exelon) and galantamine (Reminyl). The NMDA receptor antagonist is memantine (Ebixa).

According to SAMHSA's National Survey on Drug Use and Health (NSDUH), 23.2 million persons (9.4 percent of the U.S. population) aged 12 or older needed treatment for an illicit drug or alcohol use problem in 2007. Of these individuals, 2.4 million (10.4 percent of those who needed treatment) received treatment at a specialty facility (i.e., hospital, drug or alcohol rehabilitation or mental health center). Thus, 20.8 million persons (8.4 percent of the population aged 12 or older) needed treatment for an illicit drug or alcohol use problem but did not receive it. These estimates are similar to those in previous years.

Related Conferences

  1. 5th Toxicology and Applied Pharmacology Conference,                              September 19-21, 2016 Las Vegas, USA
  2. 2nd Therapeutic Drug Monitoring and Toxicogenomics Conference,                       June 09-10, 2016 Dallas, USA  
  3. 5th Pharmacovigilance Conference, April 28-29, 2016 Dubai, UAE
  4. 4th  Medicinal Chemistry & Computer Aided Drug Designing Conference, November 02-04, 2015 Atlanta, USA
  5. 2nd Antibiotics Conference, September 14-16, October 03-05, 2016 London, UK
  6. 2nd Retroviruses and Novel Drugs Conference,                                                    June 30-July 01, 2016 Cape Town, South Africa
  7. 2nd Drug Discovery & Designing Conference,                                                     Oct 31-Nov 02, 2016 Istanbul, Turkey
  8. 9th Drug Delivery Conference, June 30-July 02, 2016 New Orleans, USA
  9. Toxicology & Applied Pharmacology Conference, October 27-29, 2016 Rome, Italy
  10. Marine Drugs & Natural Products Medicine Conference,                                    July 28-30, 2016 Melbourne, Australia
  11. 4th HIV/AIDS, STDs, & STIs Conference,                                                    November 30-December 02, 2015 Hilton Atlanta Airport, Atlanta, USA
  12. 4th Immunology Conference, September 28-30, 2015 Houston, Texas, USA
  13. 2nd Infectious Diseases Conference, August 25-27, 2016 Philadelphia, USA
  14. 2nd Influenza Conference, September 12-14, 2016 Berlin, Germany
  15. Infection Prevention and Control Conference, Aug 1-2, 2016 Frankfurt, Germany
  16. 2nd Innate Immunity Conference, July 21-22, 2016 Berlin, Germany
  17. 2nd Parasitology Conference, August 01-03, 2016 Manchester, UK
  18. 2nd Neuroimmunology & Therapeutics Conference,                                        March 31-April 02, 2016 Atlanta, USA
  19. 5th Cancer Therapy Conference, September 28-30, 2015 Atlanta, Georgia, USA
  20. 4th Bacteriology and Infectious Diseases Conference,                                        May 16-18, 2016 San Antonio, USA
  21. Drug Resistance: From Mechanism to Management
  22. Drug Resistance Gordon Research Conference
  23. The World Antimicrobial Resistance Congress
  24. EACR-AACR-SIC Special Conference: Anticancer Drug Action and Drug Resistance, from Cancer Biology to the Clinic

Societies related

  1. Infectious Diseases Society of America (IDSA)
  2. Antimicrobial resistance - Royal Society
  3. American Society for Microbiology
  4. Red Cross Red Crescent Societies (IFRC)
  5. Ecuadorian Society of Medical Technologists Laboratory (SOTEMELAB)
  6. Infectious Diseases Society of America
  7. American Society for Microbiology
  8. European Society of Clinical Microbiology and Infectious Diseases
  9. Médecins Sans Frontières
  10. American Chemical Society
  11. American Federation for Medical Research

Relevant Companies

  1. National Medicines Institute
  2. Crown Bioscience, Inc.
  3. Metabolon, Inc.
  4. Redx Pharma
  5. AstraZeneca
  6. Boston Biomedical
  7. SilverPhasE Ltd.  
  8. Quay Pharma
  9. Ustar Biotechnologies (Hangzhou) Ltd.
  10. Zakłady Chemiczne Permedia S.A.

This page will be updated regularly.

This page was last updated on March 28, 2024

Conference Series Destinations